Hieber’s Pharmacy (2024)

Hieber’s Pharmacy (2024)

About this raise

Hieber’s Pharmacy is raising funds on Honeycomb. It is the oldest compounding pharmacy in Pittsburgh, Pennsylvania, and has a rich heritage. Hieber’s Pharmacy is a unique blend of traditional pharmacy services and specialized compounding and serves a diverse clientele. The business provides a combination of modern pharmacy services with a nostalgic soda fountain and has made significant historical contributions. Rosemary Mihalko founded Hieber’s Pharmacy in April 2019. The current crowdfunding campaign has a minimum target of $35,000 and a maximum target of $75,000. The campaign proceeds will be used for inventory, construction costs, hiring and staffing, and working capital.

Expand

Investment Overview

Invested this round: $75,000

Deal Terms

Total Commitments

Platform
Honeycomb
Start Date
01/11/2024
Close Date
02/25/2024
Min. Goal
$35,000
Max Goal
$75,000
Min. Investment

$100

Security Type

Debt

Payment Schedule

Quarterly

SEC Filing Type

RegCF    Open SEC Filing

Interest Rate

10.00%

Term Length

3.0 years

Company & Team

Company

Year Founded
2019
Industry
Healthcare & Pharmaceuticals
Tech Sector
Non-Tech
Distribution Model
B2C
Margin
Low
Capital Intensity
High
Location
Pittsburgh, Pennsylvania
Business Type
Growth
Company Website
Visit Website

Team

Employees
14
Prior Founder Exits?
No
Founder Name
Rosemary Sassic-Mihalko
Title
CEO

Financials

 Revenue -1.9% YoY
$1,206,050
as of FY2022
 Monthly Burn
Profitable
as of FY2022
 Cash on Hand
$32,703
as of FY2022
 Gross Margin
68%
as of FY2022

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$1,206,050

$1,228,914

COGS

$386,694

$391,752

Tax

$0

$0

 

 

Net Income

$65,754

$70,754

Summary Balance Sheet

FY 2022 FY 2021

Cash

$32,703

$54,295

Accounts Receivable

$0

$-11

Total Assets

$1,395,518

$332,319

Short-Term Debt

$41,931

$17

Long-Term Debt

$1,293,350

$288,478

Total Liabilities

$1,335,281

$288,495

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$0
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
02/25/2024 Honeycomb - $75,000 Debt Funded RegCF
05/17/2022 Honeycomb - $86,429 Debt Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Hieber’s Pharmacy on Honeycomb 2024
Platform: Honeycomb
Security Type: Debt

Follow company

Follow Hieber’s Pharmacy on Honeycomb 2024

Buy Hieber’s Pharmacy's Deal Report

Warning: according to the close date for this deal, Hieber’s Pharmacy may no longer be accepting investments.

Hieber’s Pharmacy Deal Report

Get Kingscrowd's comprehensive report on Hieber’s Pharmacy including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Hieber’s Pharmacy is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Hieber’s Pharmacy deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge